Medical management of dysfunctional uterine bleeding

G A Irvine, Gillian Anne Irvine, Iain T. Cameron, I. T. Cameron
Bailliere's best practice & research. Clinical obstetrics & gynaecology · 1999 · vol. 13(2) , pp. 189–202 · doi:10.1053/beog.1999.0017 · PMID:10755037 · W2055748849
Review OA: closed CC0 ⤵ 16 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This review examines current medical treatments for dysfunctional uterine bleeding, focusing on hormonal and non-hormonal pharmacologic options.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Complaints of excessive menstrual bleeding (menorrhagia) have a substantial impact on gynaecological services and in most cases no organic pathology is identified. Up to 50% of women who present with menorrhagia have blood losses within the normal range. Medical therapy is indicated for patients who do not wish surgery, or for whom surgery is unsuitable. Nonsteroidal anti-inflammatory drugs and tranexamic acid offer a simple therapy to be taken during menses, with reductions in menstrual blood loss (MBL) of 25-35% and 50% respectively. Danazol and the gonadatrophin-releasing hormone analogues are highly effective, but their side-effects make them suitable only for short-term use. The combined oral contraceptive pill and the levonorgestrel intrauterine system give reductions in MBL of 50% and 80%, with additional contraceptive cover. Cyclical progestogens are the most commonly prescribed therapy in the United Kingdom but they are ineffective for the management of ovulatory menorrhagia unless taken at high doses (10-15 mg daily) for 3 weeks out of 4.

My notes (saved in your browser only)

MeSH descriptors

Menorrhagia Antifibrinolytic Agents Antifibrinolytic Agents Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Non-Steroidal Contraceptives, Oral, Combined Contraceptives, Oral, Combined Danazol Danazol Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Levonorgestrel Levonorgestrel Menorrhagia Progestins Progestins Tranexamic Acid Tranexamic Acid

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (62)

Cited by (13)

Source provenance

openalex
last seen: 2026-05-11T05:39:31.692385+00:00
pubmed
last seen: 2026-10-08T20:59:21.759586+00:00
unpaywall
last seen: 2026-10-10T06:25:47.132674+00:00
License: CC0 · commercial use OK